Adoption of medications in substance abuse treatment: Priorities and strategies of single state authorities

Journal of Psychoactive Drugs

Volumn 42, Issue , 2010, Pages 227-238

  Rieckmann, Traci ^a   Kovas, Anne E ^b   Rutkowski, Beth A ^c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Barriers to adoption; Evidence base practices; Facilitative factors; Medication assisted treatment; National quality forum; Single state authority (SSA)

Indexed keywords

ADDICTION; ARTICLE; DRUG DEPENDENCE TREATMENT; EVIDENCE BASED PRACTICE; HEALTH CARE PLANNING; HUMAN; STANDARD;

EVIDENCE-BASED PRACTICE; HEALTH PLAN IMPLEMENTATION; HUMANS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS;

EID: 79952111434     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2010.10400546     Document Type: Article

References (99)

1. Addiction Technology Transfer Center Network. 2010. NIDAJSAMHSA Blending Initiative. Available at http://www.attcnetwork.org/explore/priorityareas/science/blendinginitiative/index.asp.
2. Addiction Technology Transfer Center Network. 2005. Buprenorphine Treatment: A Training for Multidisciplinary Addiction Professionals. Available at http://www.nattc.org/explore/priorityareas/science/blendinginitiative/buptx/.
3. Amass, L.; Ling, W.; Freese, T.; Reiber, C.; Annon, J.; Cohen, A.; McCarty, D.; Reid, M.; Brown, L.; Clark, C.; Ziedonis, D.; Krejci, J.; Stine, S.; Winhusen, T.; Brigham, G.; Babcock, D.; Muir, J.; Buchan, B. & Horton, T. 2004. Bringing buprenorphine-naloxone detoxification to community treatment providers: The NIDA clinical trials network field experience. American Journal of Addictions 13 (I): 542-66.
4. Ambert, A.; Adler, P.; Adler, P. & Detzner, D. 1995. Understanding and evaluating qualitative research. Journal of Marriage and the Family 57: 879-93.
5. Anton, R.F.; Moak, D.H.; Waid, L.R.; Latham, P.K.; Malcolm, R.J. & Dian, J.K. 1999. Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: Results of a placebo-controlled trial. American Journal of Psychiatry 156: 1758-64.
6. Bailey, J.E.; Campagna, E. & Dart, R.C. 2009. The underrecognized toll of prescription opioid abuse on young children. Annals of Emergency Medicine 53 (4): 419-24.
7. Balas, E.A. & Boren, S.A. 2000. Managing clinical knowledge for health care improvement. In: J. Bemmel & A.T. McCray (Eds.) Yearbook of Medical Informatics: Patient-Centered Systems. Stuttgart, Germany: Schattauer Verlagsgesellschaft mbH.
8. Bett, P.; Rodgers, J. & Bloch, D. 2001. A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence. Addiction 96: 683-90.
9. Bell, J.R.; Butler, B.; Lawrance, A.; Batey, R. & Salmelainen, P. 2009. Comparing overdose mortality associated with methadone and buprenorphine treatment. Drug and Alcohol Dependence 104: 73-77.
10. Birnbaum, H.G.; White, A.; Reynolds, J.; Greenberg, P.E.; Zhang, M.; Vallow, S.; Schein, J.R. & Katz, N. 2006. Estimated costs of prescription opioid analgesic abuse in the United States in 2001: A societal perspective. Clinical Journal of Pain 22 (8): 667-76.
11. Brewer, C. 1992. Controlled trials of Antabuse in alcoholism: The importance of supervision and adequate dosage. Acta Psychiatrica Scandinavica Supplementum 369: 51-58.
12. Brewer, C.; Meyers, R.J. & Johnsen, J. 2000. Does disulfiram help to prevent relapse in alcohol abuse? CNS Drugs 14(5): 329-41.
13. Brown, B. & Flynn, P. 2002. The federal role in drug abuse technology transfer: A history and perspective. Journal of Substance Abuse Treatment 22: 245-57.
14. Capoccia, VA. 2006. The evolution of the Robert Wood Johnson Foundation’s approach to alcohol and drug addiction. In: S.L. Isaacs & J.R. Knickman (Eds.) To Improve Health and Health Care, Volume IX. San Francisco: Jossey-Bass.
15. Centers for Disease Control and Prevention (CDC). 2002. Methadone Maintenance Treatment. Atlanta, GA: Centers for Disease Control and Prevention.
16. Chick, J.; Anton, R.; Checinski, K.; Croop, R.; Drummond, D.C.; Farmer, R.; Labriola, D.; Marshall, J.; Moncrieff, J.; Morgan, M.Y.; Peters, T. & Ritson, B. 2000. A multicentre, randomized, double-blind, placebocontrolled trial of naltrexone in the treatment of alcohol dependence or abuse. Alcohol and Alcoholism 35 (6): 587-93.
17. Chriqui, J.F.; Terry-McElrath, Y.; McBride, D.C.; Eidson, S.S. & VanderWaal, C.J. 2007. Does state certification or licensure influence outpatient substance abuse treatment program practices? Journal of Behavioral Health Services and Research 34 (3): 309-28.
18. Chriqui, J.F.; Vanderwaal, C.J.; Bishop, R.M.; McBride, D.C. & Longshore, D.Y. 2006. State drug policy reform movement: The use of ballot initiatives to promote diversion to drug treatment. Journal of Drug Issues 36 (3): 619-48.
19. Clark, R.E., Samnaliev, M. & McGovern, M.P. 2009. Impact of substance disorders on medical expenditures for Medicaid beneficiaries with behavioral health disorders. Psychiatric Services 60: 35-42.
20. Comer, S.D.; Sullivan, M.A. & Walker, E.A. 2005. Comparison of intravenous buprenorphine and methadone self-administration by recently detoxified heroin-dependent individuals. Journal of Pharmacology and Experimental Therapeutics 315: 1320-30.
21. Crabtree, B.F. & Miller, W.L. 1999. Doing Qualitative Research. Thousand Oaks, CA: Sage Publications.
22. Creswell, J.W. 2009. Research Design: Qualitative, Quantitative, and Mixed Methods Approaches. Third Edition. Thousand Oaks, CA: Sage Publications.
23. Creswell, J. & Plano Clark, V. 2007. Designing and Conducting Mixed Methods Research. Thousand Oaks, CA: Sage Publications.
24. Donny, E.C.; Walsh, S.L.; Bigelow, G.E.; Eissenberg, T. & Stitzer, M.L. 2002. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans. Psychopharmacology 161: 202-12.
25. Doran, C.M.; Shanahan, M.; Mattick, R.P.; Ali, R.; White, J. & Bell, J. 2003. Buprenorphine versus methadone maintenance: A cost-effectiveness analysis. Drug and Alcohol Dependence 71: 295-302.
26. Drug Addiction Treatment Act of 2000 (DATA). 2000. U.S. Public Law 106-310; enacted October 17, 2000, by the 106th Congress.
27. Ducharme, L.J. & Roman, P.M. 2009. Opioid treatment programs in the Clinical Trials Network: Representativeness and buprenorphine adoption. Journal of Substance Abuse Treatment 37 (I): 90-94.
28. Ducharme, L.J. & Abraham, A.J. 2008. State policy influence on the early diffusion of buprenorphine in community treatment programs. Substance Abuse Treatment, Prevention, and Policy 3: 17.
29. Ducharme, L.J.; Knudsen, H.K.; Roman, P.M. & Johnson, J.A. 2007. Innovation adoption in substance abuse treatment: Exposure, trialability, and the clinical trials network. Journal ofSubstance Abuse Treatment 32 (4): 321-29.
30. Farrell, M.; Ward, J.; Mattick, R.; Hall, W.; Stimson, G.V.; des Jarlais, D.; Gossop, M. & Strang, J. 1994. Methadone maintenance treatment in opiate dependence: A review. British Medical Journal 309: 997-1001.
31. Fiellin, D.A.; Pantalon, M.V.; Pakes, J.P.; O’Connor, P.G.; Chawarski, M. & Schottenfeld, R.S. 2002. Treatment of heroin dependence with buprenorphine in primary care. American Journal of Drug and Alcohol Abuse 28 (2): 231-41.
32. Fixsen, D.L.; Naoom, S.F.; Blase, K.A.; Friedman, R.M. & Wallace F. 2005. Implementation Research: A Synthesis of the Literature. Tampa, FL: University of South Florida, Louis de la ParteFlorida Mental Health Institute, The National Implementation Research Network.
33. Fuller, B.E.; Rieckmann, T.; McCarty, D.; Smith, K.W. & Levine, H. 2005. Adoption of naltrexone to treat alcohol dependence. Journal of Substance Abuse Treatment 28: 273-80.
34. Garbutt, J.C. 2010. Efficacy and tolerability of naltrexone in the management of alcohol dependence. Current Pharmaceutical Design May 20. [Epub ahead of print].
35. Garbutt, J.C. 2009. The state of pharmacotherapy for the treatment of alcohol dependence. Journal of Substance Abuse Treatment 36 (1): S15-23.
36. Garbutt, J.C.; West, S.L.; Carey, T.S.; Lohr, K.N. & Crews, F.T. 1999. Pharmacological treatment of alcohol dependence: A review of the evidence. Journal of the American Medical Association 281 (14): 1318-25.
37. Garner, B.R. 2009. Research on the diffusion of evidence-based treatments within substance abuse treatment: A systematic review. Journal of Substance Abuse Treatment 36: 376-99.
38. Gelber, S. & Rinaldo, D. 2005. State Substance Abuse Agencies and their Placement within Government: Impact on Organizational Performance and Collaboration in 12 States. Rockville, MD: Substance Abuse and Mental Health Services Administration, United States Department of Health and Human Services.
39. Gold, P.; Glynn, S. & Mueser, K. 2006. Challenges to implementing and sustaining comprehensive mental health service programs. Evaluation & the Health Professions 29 (2): 195-218.
40. Greenfield, L. & Fountain, D. 2000. Influence of time in treatment and follow-up duration on methadone treatment outcomes. Journal of Psychopathology and Behavioral Assessment 22 (4): 353-64.
41. Isett, K.R.; Burnam, M.A.; Coleman-Beattie, B.; Hyde, P.S.; Morrissey, J.P.; Magnabosco, J.; Rapp, C.A.; Ganju, V. & Goldman, H.H. 2007. The state policy context of implementation issues forevidence-based practices in mental health. Psychiatric Services 58: 914-21.
42. Johnson, R.E.; Eissenberg, T.; Stitzer, M.L.; Strain, E.C.; Liebson, I.A. & Bigelow, G.E. 1995. A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence. Drug and Alcohol Dependence 40: 17-25.
43. Kakko, J.; Svanborg, K.; Kree, M. & Hellig, M. 2003. 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: A randomized, placebocontrolled trial. Lancet 361: 662-68.
44. Knudsen, H.; Ducharme L. & Roman, P. 2007. The adoption of medications in substance abuse treatment: Associations with organizational characteristics and technology clusters. Drug and Alcohol Dependence 87: 164-74.
45. Knudsen, H.K.; Ducharme L.J. & Roman, P.M. 2006. Early adoption of buprenorphine in substance abuse treatment centers: Data from the private and public sectors. Journal of Substance Abuse Treatment 30 (4): 363-73.
46. Knudsen, H.; Abraham, A.; Johnson, J. & Roman, P. 2009. Buprenorphine adoption in the National Drug Abuse Treatment Clinical Trials Network. Journal ofSubstance Abuse Treatment 37 (3): 307-12.
47. Knudsen, H.K.; Ducharme, L.J.; Roman, P.M. & Link, T. 2005. Buprenorphine diffusion: The attitudes of substance abuse treatment counselors. Journal of Substance Abuse Treatment 29: 95-106.
48. Kovas, A.E.; McFarland, B.H.; McCarty, D.J.; Boverman, J.F. & Thayer, J.A. 2007. Buprenorphine for acute heroin detoxification: Diffusion of research into practice. Journal ofSubstance Abuse Treatment 32 (2): 199-206.
49. Krampe, H. & Ehrenreich, H. 2010. Supervised disulfiram as adjunct to psychotherapy in alcoholism treatment. Current Pharmaceutical Design May 20 [Epub ahead of print].
50. Leavitt S.B. 2002. Evidence for the Efficacy of Naltrexone in the Treatment of Alcohol Dependence (Alcoholism). Addiction Treatment Forum: Naltrexone Clinical Update. Available at www.atforum.com.
51. Lehman, W.K.; Greener, J.M. & Simpson, D. 2002. Assessing organizational readiness for change. Journal of Substance Abuse Treatment 22: 197-209.
52. Lincoln, Y.S. & Guba, E.G. 1985. Naturalistic Inquiry. Newbury Park, CA: Sage Publications.
53. Ling, W.; Hillhouse, M.; Domier, C.; Doraimani, G.; Hunter, J.; Thomas, C.; Jenkins, J.; Hasson, A.; Anon, J.; Saxon, A.; Selzer, J.; Boverman, J. & Bilangi, R. 2009. Buprenorphine tapering schedule and illicit opioid use. Addiction 104 (2): 256-65.
54. Ling, W.; Charuvastra, C.; Collins, J.F.; Batki, S.; Brown, L.S. Jr.; Kintaudi, P.; Wesson, D.R.; McNicholas, L.; Tusel, D.J.; Malkerneker, U.; Renner, J.A. Jr.; Santos, E.; Casadonte, P.; Fye, C.; Stine, S.; Wang, R.I. & Segal, D. 1998. Buprenorphine maintenance treatment of opiate dependence: A multicenter, randomized clinicaltrial. Addiction 93: 475-86.
55. Lofland, J.; Snow, D.; Anderson, L. & Lofland, L. 2006. Analyzing Social Settings: A Guide to Qualitative Observation and Analysis. Fourth Ed. Belmont, CA: Wadsworth.
56. Luborsky, M. 1994. The identification and analysis of themes and patterns. In: J. Gubrium & A. Sankar (Eds.) Qualitative Methods in Aging Research. Thousand Oaks, CA: Sage Publications.
57. Magnabosco, J. 2006. Innovations inmentalhealth services implementation: A report on state-level data from the U.S. Evidence-Based Practices Project. Implementation Science I: 13.
58. Marinelli-Casey, P.; Domier, C.P & Rawson, R.A. 2002. The gap between research and practice in substance abuse treatment. Psychiatric Services 53 (8): 984-87.
59. Mark, T.; Kassed, C.; Vandivort-Warren, R.; Levit, K. & Kranzler, H. 2009. Alcohol and opioid dependence medications: Prescription trends overall and by physician specialty. Drug and Alcohol Dependence 99: 345-49.
60. Mark, T.L.; Levit, K.R.; Coffey, R.M.; McKusick, D R.; Harwood, H.J.; King, E.C.; Bouchery, E.; Genuardi, J.S.; Vandivort-Warren, R.; Buck, J.A. & Ryan, K. 2007. National Expenditures for Mental Health Services and Substance Abuse Treatment, 1993-2003, SAMHSA Publication No. SMA 07-4227. Rockville, MD: Substance Abuse and Mental Health Services Administration.
61. Mark, T.L.; Woody, G.E.; Juday, T. & Kleber, H.D. 2001. The economic costs of heroin addiction in the United States. Drug and Alcohol Dependence 61: 195-206.
62. Marshall, C. & Rossman, G. 2006. Designing Qualitative Research. Fourth Ed. Thousand Oaks, CA: Sage Publications.
63. Martino, S.; Brigham, G.S.; Higgins, C.; Gallon, S.; Freese, T.E.; Albright, L.M.; Hulsey, E.G.; Krom, L.; Storti, S.A.; Perl, H.; Nugent, CD.; Pintello, D. & Condon, T.P. 2010. Partnerships and pathways of dissemination: The National Institute on Drug Abuse-Substance Abuse and Mental Health Services Administration Blending Initiative in the Clinical Trials Network. Journalof Substance Abuse Treatment 38 (Suppl 1): S31-43.
64. Mattick, R.P.; Breen, C.; Kimber, J. & Davoli, M. 2003. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Systematic Reviews 2: CD002209.
65. McCarty, D. & Rieckmann, T. In press. The treatment system for alcohol and drug disorders. In: B. Levin; J. Petrila & K.D. Hennessy (Eds.) Mental Health Services: A Public Health Perspective. Third Ed. New York: Oxford University Press.
66. McCarty, D.; Rieckmann, T.; Green, C.A.; Gallon, S. & Knudsen, J. 2004. Training rural practitioners to use buprenorphine: Using The Change Book to facilitate technology transfer. Journal of Substance Abuse Treatment 26: 203-8.
67. McGinnis, J.M. & Foege, W.H. 1999. Mortality and morbidity attributable to use of addictive substances in the United States. Proceedings of the Association of American Physicians 111: l09-18.
68. McLellan, A.T. 2002. Technology transfer and the treatment of addiction: What can research offer practice? Journal of Substance Abuse Treatment 22 (4): 169-70.
69. McLellan, A.T.; Weinstein, R.L.; Shen, Q.; Kendig, C. & Levine, M. 2005. Improving continuity of care in a public addiction treatment system with clinical case management. American Journal on Addictions 14: 426-40.
70. McLellan, A.T.; Lewis, D.C.; O’Brien, C.P & Kleber, H.D. 2000. Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. Journal oftheAmerican Medical Association 284 (13): 1689-95.
71. Miles, M.B. & Huberman, A.M. 1994. Qualitative Data Analysis: An Expanded Sourcebook. Thousand Oaks, CA: Sage Publications.
72. Monti, P.M.; Rohsenow, D.J.; Swift, R.M.; Gulliver, S.B.; Colby, S.M.; Mueller, T.l.; Brown, R.A.; Gordon, A.; Abrams, D.B.; Niaura, R.S. & Asher, M.K. 2001. Naltrexone and cue exposure with coping and communication skills training for alcoholics: Treatment process and 1-year outcomes. Alcoholism: Clinical and Experimental Research 25: 1634-47.
73. Mulvey, K.P.; Hubbard, S. & Hayashi, S. 2003. A national study of the substance abuse treatment workforce. Journal of Substance Abuse Treatment 24: 51-57.
74. NIH Consensus Panel. 1998. National consensus development panel on effective medical treatment of opiate addiction. Journal of the American Medical Association 280: 1936-43.
75. National Quality Forum (NQF). 2007. National Voluntary Consensus Standards for the Treatment of Substance Use Conditions: Evidence-Based Treatment Practices. Washington, DC: National Quality Forum.
76. National Quality Forum (NQF). 2005. Evidence-Based Treatment Practices for Substance Use Disorders, Workshop Proceedings. Washington, DC: National Quality Forum.
77. O’Connor P.; Oliveto, A.; Shi, J.; Triffleman, E.G.; Carroll, K.M.; Kosten, T.R.; Rounsaville, B.J.; Pakes, J.A. & Schottenfeld, R.S. 1998. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. American Journal of Medicine 105 (2): 100-05.
78. O'Malley, S.S.; Jaffe, A.J.; Chang, G.; Schottenfeld, R.S.; Meyer, R.E. & Rounsaville, B. 1992. Naltrexone and coping skills therapy for alcohol dependence: A controlled study. Archives of General Psychiatry 49: 881-87.
79. Proctor, E.K.; Knudsen, K.J.; Fedoravicius, N.; Hovmand, P.; Rose, A. & Perron, B. 2007. Implementation of evidence-based practice in community behavioral health: Agency director perspectives. Administration and Policy in Mental Health and Mental Health Services Research 34 (5): 479-88.
80. Rapp, C.A.; Bond, G.R.; Becker, D.R.; Carpinello, S.E.; Nikkel, R.E. & Gintoli, G. 2005. The role of state mental health authorities in promoting improved client outcomes through evidence-based practice. Community Mental Health Journal 41 (3): 347-63.
81. Rawson, R.A.; Hasson, A.L.; Huber, A.M.; McCann, M.J. & Ling W. 1998. A 3-year progress report on the implementation of LAAM in the United States. Addiction 93 (4): 533-40.
82. Rehm, J.; Mathers, C.; Popova, S.; Thavorncharoensap, M.; Teerawattananon, Y. & Patra, J. 2009. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 373: 2223-33.
83. Rieckmann, T.R.; Kovas, A.E.; Fussell, H.E. & Stettler, N.M. 2009. Implementation of evidence-based practices for treatment of alcohol and drug disorders: The role of the state authority. Journal of Behavioral Health Services & Research 36 (4): 407-19.
84. Rieckmann, T.; Fuller, B.; Daley, M.; Thomas, C. & McCarty, D. 2007. Client and counselor attitudes toward the use of medications. Journal of Substance Abuse Treatment 32: 207-15.
85. Rogers, E.M. 2003. Diffusion of Innovations. Fifth Ed. New York: Free Press.
86. Roman, P.M. & Johnson, J.A. 2002. Adoption and implementation of new technologies in substance abuse treatment. Journal of Substance Abuse Treatment 22: 211-18.
87. Saxon, A. & McCarty, D. 2005. Challenges in the adoption of new pharmacotherapeutics for addiction to alcohol and other drugs. Pharmacology and Therapeutics 108 (I): 119-28.
88. Simpson, D.D. 2002. A conceptual framework for transferring research to practice. Journal ofSubstance Abuse Treatment 22: 171-82.
89. Stirman, S.W.; Crits-Christoph, P. & DeRubeis, R.J. 2004. Achieving successful dissemination of empirically supported psychotherapies: A synthesis of dissemination theory. Clinical Psychology: Science and Practice 11: 343-59.
90. Substance Abuse and Mental Health Services Administration, Office of Applied Studies (SAMHSA). 2009a. Results from the 2008 National Survey on Drug Use and Health: National Findings. NSDUH Series H-36, HHS Publication No. SMA 09-4434. Rockville, MD: SAMHSA.
91. Substance Abuse and Mental Health Services Administration, Office of Applied Studies (SAMHSA). 2009b. Treatment Episode Data Set (TEDS) Highlights - 2007 National Admissions to Substance Abuse Treatment Services. OAS Series #S-45, HHS Publication No. (SMA) 09-4360, Rockville, MD: SAMHSA.
92. Sullivan, L.E.; Chawarski, M.; O’Connor, P.G.; Schottenfeld, R.S. & Fiellin, D.A. 2005. The practice of office-based buprenorphine treatment of opioid dependence: Is it associated with new patients entering into treatment? Drug and Alcohol Dependence 79: 113-16.
93. Thomas, C.P.; Wallack, S.S.; Lee, S.; McCarty, D. & Swift, R. 2003. Research to practice: Adoption of naltrexone in alcoholism treatment. Journal ofSubstance Abuse Treatment 24: I -II.
94. Trochim, W. & Donnelly, J.P 2006. The Research Methods Knowledge Base. Third Ed. Mason, OH: Atomicdog Publishing.
95. Volpicelli, J.R.; Alterman, AI.; Hayashida, M. & O’Brien, C.P. 1992. Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry 49: 876-80.
96. Wallack, S.S.; Thomas, C.P.; Martin, T.C.; Chilingerian, J. & Reif, S. 2010. Substance abuse treatment organizations as mediators of social policy: Slowing the adoption of a congressionally approved medication. Journal of Behavioral Health Services and Research 37: 64-78.
97. White, A.G.; Birnbaum, H.G.; Mareva, M.N.; Daher, M.; Vallow, S.; Schein, J. & Katz, N. 2005. Direct costs of opioid abuse in aninsured population in the United States. Journal of Managed Care Pharmacy 11 (6): 469-79.
98. Woody, G.E.; Poole, S.A.; Subramaniam, G.; Dugosh, K.; Bogenschutz, M.; Abbott, P.; Patkar, A.; Publicker, M.; McCain, K.; Sharpe Potter, J.; Forman, R.; Vetter, V.; McNicholas, L.; Blaine, J.; Lynch, K.G. & Fudala, P. 2008. Extended vs. short-term buprenorphine-naloxone for treatment of opioid-addicted youth: A randomized trial. Journal of the American Medical Association 300 (17): 2003-11.
99. Ziedonis, D.; Hitsman, B.; Beckham, J.C.; Zvolensky, M.; Adler, L.E.; Audrain-McGovern, J.; Breslau, N.; Brown, R.A.; George, T.P.; Williams, J.; Calhoun, P.S. & Riley, W.T. 2008. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine and Tobacco Research 10: 1691-1715.